Literature DB >> 3117535

Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

.   

Abstract

In 1984 the European Study Group on Antibiotic Resistance (ESGAR), which is made up of 29 laboratories in 12 European countries, consecutively collected gram-negative bacilli and staphylococci isolates from blood and using the microdilution method performed susceptibility testing with 11 beta-lactam antibiotics. A total of 2,578 isolates were collected; 68% were gram-negatives and 32% staphylococci. Pseudomonas spp. accounted for 12% of the strains, Enterobacter spp. 7%, Serratia spp. 3%, indole-positive Proteus spp. 1%, Citrobacter spp. and Morganella spp. 0.9% each. Strains with inducible beta-lactamases were detected by the cefoxitin disc diffusion method in 11% of all gram-negatives and in 67% of the relevant species. The production of inducible beta-lactamase was confirmed by elevated MICs to and decreased killing by piperacillin, cefotaxime and ceftazidime after induction of enzyme production with low concentrations of cefoxitin. This phenomenon was not observed with mecillinam or the new penem Sch 34343.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117535     DOI: 10.1007/bf02013111

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  24 in total

1.  Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy.

Authors:  R A Weinstein
Journal:  Infect Control       Date:  1986-02

2.  Assay of gentamicin concentrations in serum specimens by microbiological and radioenzymatic methods.

Authors:  K Dornbusch
Journal:  Scand J Infect Dis       Date:  1977

3.  Class I beta-lactamase expression in Pseudomonas aeruginosa and cephalosporin resistance.

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

Review 4.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

5.  In vivo selection of resistance to multiple cephalosporins by enterobacter cloacae.

Authors:  P R Murray; G G Granich; D J Krogstad; A C Niles
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

6.  Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.

Authors:  W Cullmann; W Dick
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

7.  Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.

Authors:  B G Shearer; N J Legakis
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

8.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

9.  Cefoxitin sensitivity as a marker for inducible beta-lactamases.

Authors:  V A Moritz; P B Carson
Journal:  J Med Microbiol       Date:  1986-05       Impact factor: 2.472

10.  Resistance to beta-lactamase-stable cephalosporin antibiotics in strains of Enterobacteriaceae and Pseudomonas aeruginosa isolated from blood cultures.

Authors:  K J Towner; M Massam
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790

View more
  6 in total

Review 1.  Class I beta-lactamases. Induction and derepression.

Authors:  I Phillips; K Shannon
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

2.  Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones.

Authors:  R N Jones; A L Barry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

Review 3.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

4.  Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.

Authors:  C Stark; C Edlund; M Hedberg; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

Review 5.  Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.

Authors:  R Sutherland
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

6.  Direct RNA-based detection and differentiation of CTX-M-type extended-spectrum β-lactamases (ESBL).

Authors:  Claudia Stein; Oliwia Makarewicz; Yvonne Pfeifer; Christian Brandt; João Costa Ramos; Mareike Klinger; Mathias W Pletz
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.